Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gum graft technique aims to strengthen dental implants

NCT ID NCT07626866

Disease control Sponsor: I.M. Sechenov First Moscow State Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of gum graft for people with thin gums around dental implants. 32 adults will receive either a graft with an extra piece of skin or a standard graft. The goal is to see which method better increases gum thickness and width, and improves comfort and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Jun 2024

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. Written informed consent for participation in the study; 2. Age between 18 and 45 years; 3. Bounded edentulous defects of the upper or lower jaw involving 1-2 teeth combined with soft tissue thickness deficiency around dental implants (\<2 mm); 4. Teeth without periodontal pathology, with probing depth not exceeding 3 mm throughout the gingival sulcus; 5. Satisfactory level of oral hygiene; 6. Absence of systemic diseases in the stage of exacerbation or decompensation. Non-inclusion criteria: 1. Patients who previously underwent connective tissue graft harvesting from the same donor site; 2. Patients with impacted third molars in the donor site area; 3. Presence of concomitant diseases in the stage of exacerbation or decompensation; 4. Patients with malignant neoplasms, as well as patients who underwent radiation therapy or chemotherapy within the previous 5 years; 5. Patients with a smoking history of more than 10 years. Exclusion Criteria: 1. Patient refusal to continue participation in the study; 2. Pregnant or breastfeeding women; 3. Patients with coagulation disorders (hemophilia, von Willebrand disease, or anticoagulant therapy); 4. Patients with diseases affecting soft tissue healing processes (insulin-dependent diabetes mellitus).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Soft tissue atrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Soft tissue atrophy

Contacts and locations

Locations

  • I.M. Sechenov First Moscow State Medical University (Sechenov University)

    Moscow, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.